Tropisetron (Navoban)
Revision as of 03:24, 18 November 2017 by Warner-admin (talk | contribs) (Text replacement - "5HT3" to "5-HT3")
Mechanism of action
From NCI: "An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in suppression of chemotherapy-and radiotherapy-induced nausea and vomiting."
History of FDA approval
Not FDA-approved; available in several countries
Also known as
ICS 205-930, Setrovel